Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

120.45
-0.4300-0.36%
Volume:5K
Turnover:586.53K
Market Cap:543.23M
PE:6.25
High:120.86
Open:120.78
Low:120.45
Close:120.88
52wk High:131.68
52wk Low:92.10
Shares:4.51M
Float Shares:4.51M
Volume Ratio:0.56
T/O Rate:0.11%
Dividend:1.12
Dividend Rate:0.93%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.63
PE(LYR):5.54

Loading ...

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
33 mins ago

Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor

MT Newswires Live
·
40 mins ago

Abbott Receives FDA Approval for New Cardiomems HF System Capabilities That Help Patients Engage in the Care of Their Heart Condition

THOMSON REUTERS
·
1 hour ago

Abbott - Cardioguide HF App and Dynamic Treatment Plan to be Available Later This Year

THOMSON REUTERS
·
1 hour ago

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
2 hours ago

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
2 hours ago

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03

Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Debate Heats Up

Simply Wall St.
·
Oct 03

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

AbbVie Joins US Government Pilot to Test Drug Discount Rebates

Reuters
·
Oct 03

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar

THOMSON REUTERS
·
Oct 03

Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program

THOMSON REUTERS
·
Oct 03

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Oct 03

Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure

Dow Jones
·
Oct 03

Bayer to invest $2.2B in new manufacturing site in New Albany, Ohio

TIPRANKS
·
Oct 03

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
Oct 03

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
Oct 03

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS
·
Oct 03